TAYTULLA
Peaknorethindrone acetate and ethinyl estradiol, and ferrous fumarate
NDAORALCAPSULE
Approved
Apr 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TAYTULLA (norethindrone acetate and ethinyl estradiol, and ferrous fumarate) by Ichnos Glenmark Innovation is ovulation. First approved in 2013.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TAYTULLA is an oral contraceptive combining norethindrone acetate, ethinyl estradiol, and ferrous fumarate in capsule form. It prevents pregnancy by suppressing ovulation through hormonal mechanisms. The ferrous fumarate component addresses iron loss during menstruation, differentiating it from standard oral contraceptives.
$0.03BPart D
PeakProduct is in peak commercial phase with modest Medicare Part D penetration; established commercial infrastructure supports mid-sized team focused on patient retention and market stability.
Mechanism of Action
ovulation.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TAYTULLA positions you in a stable, mature contraceptive franchise with established market dynamics and patient base. Roles focus on market maintenance, patient education, and competitive differentiation rather than high-growth expansion or clinical innovation.
Brand ManagerField Sales Representative
Worked on TAYTULLA at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.